Skip to main content
OpenTrials

Clinical trial condition

Headache Disorders, Primary

Explore clinical trials studying Headache Disorders, Primary. Study availability and eligibility vary by location and protocol.

1,287 public trials 152 recruiting studies
Refine in advanced search Browse all conditions

Headache Disorders, Primary trial results

Recruiting

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

NCT05125302

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Rehabilitation & Neurological Services /ID# 229969 Huntsville, Alabama, United States
  • The Center for Clinical Trials - Saraland /ID# 231546 Saraland, Alabama, United States
  • Rezen Clinical Trials /ID# 282831 Glendale, Arizona, United States
  • Velocity Clinical Research - Phoenix /ID# 274478 Phoenix, Arizona, United States
View all 129 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

NCT07645924

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Central Research Associates, LLC (CRA) dba Flourish Research Birmingham, Alabama, United States
  • AMR Mobile Mobile, Alabama, United States
  • TrialSphere Chandler, Arizona, United States
  • Arkansas Clinical Research Little Rock, Arkansas, United States
View all 115 locations
View Trial Details
Recruiting

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558

Conditions
Brain Diseases, Central Nervous System Diseases, Chronic Migraine, +6 more
Locations
  • On Hospital /ID# 285157 Busan, Busan Gwang Yeogsi, South Korea
  • Ryu Sang Hyo Neurosurgery Clinic /ID# 284804 Busan, Busan Gwang Yeogsi, South Korea
  • Dong-A University Medical Center /ID# 275321 Busan, Busan Gwang Yeogsi, South Korea
  • Chungnam National University Hospital /ID# 284724 Daejeon, Daejeon Gwang Yeogsi, South Korea
View all 36 locations
View Trial Details
Recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

NCT07646613

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Sunwise Clinical Research, Llc Walnut Creek, California, United States
  • Clinical Neuroscineces Solutions - Orlando Orlando, Florida, United States
  • Clinical Neuroscineces Solutions Orlando, Florida, United States
  • M3 Wake Research - Las Vegas Rainbow Las Vegas, Nevada, United States
View Trial Details
Recruiting

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

NCT06248671

Conditions
Brain Diseases, Central Nervous System Diseases, Episodic Migraine, +4 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • University Hospital, Akershus Lørenskog, Norway
  • Oslo University Hospital, Rikshospitalet Oslo, Norway
  • Oslo University Hospital, Ullevål Oslo, Norway
View Trial Details
Recruiting

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT06810505

Conditions
Brain Diseases, Central Nervous System Diseases, Chronic Migraine, +4 more
Locations
  • Rehabilitation and Neurological Services /ID# 270782 Huntsville, Alabama, United States
  • Preferred Research Partners - Fayetteville /ID# 270419 Fayetteville, Arkansas, United States
  • Preferred Research Partners /ID# 270389 Little Rock, Arkansas, United States
  • Advanced Research Center /ID# 270257 Anaheim, California, United States
View all 64 locations
View Trial Details

Related conditions